Umeå University's logo

Response: Atrial impairment in transthyretin cardiac amyloidosis: an early marker of cardiac involvement and a prognostic factor 2018 (English)In: Amyloid: Journal of Protein Folding Disorders, ISSN 1350-6129, E-ISSN 1744-2818, Vol. 25, no 2, p. 136-136Article in journal, Letter (Refereed) Published

Place, publisher, year, edition, pages

Taylor & Francis Group, 2018. Vol. 25, no 2, p. 136-136

National Category

Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)

Identifiers

URN: urn:nbn:se:umu:diva-153001DOI: 10.1080/13506129.2018.1450241ISI: 000446965400012PubMedID: 29529882Scopus ID: 2-s2.0-85043693966OAI: oai:DiVA.org:umu-153001DiVA, id: diva2:1260077

Available from: 2018-11-01 Created: 2018-11-01 Last updated: 2023-03-23Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Henein, Michael Y.Lindqvist, Per

Search in DiVA

By author/editor

Henein, Michael Y.Lindqvist, Per

By organisation

Cardiology

In the same journal

Amyloid: Journal of Protein Folding Disorders

On the subject

Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)

Search outside of DiVA

GoogleGoogle ScholarTotal: 494 hits